Predicting bacterial fitness cost associated with drug resistance

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 4, 2012, Pages 928-932

  Guo, Beining ^a,b   Abdelraouf, Kamilia ^a   Ledesma, Kimberly R ^a   Nikolaou, Michael ^a   Tam, Vincent H ^a  

^a UNIVERSITY OF HOUSTON   (United States)

^b FUDAN UNIVERSITY   (China)

Author keywords

Biofitness; In vitro time growth; Modelling; Multidrug resistant bacteria

Indexed keywords

ANTIBIOTIC AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL FITNESS COST; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIUM CULTURE; COCULTURE; IN VITRO STUDY; MATHEMATICAL MODEL; NONHUMAN; PSEUDOMONAS AERUGINOSA;

ACINETOBACTER BAUMANNII; BACTERIAL LOAD; DRUG RESISTANCE, BACTERIAL; ENERGY METABOLISM; HUMANS; MODELS, THEORETICAL; PSEUDOMONAS AERUGINOSA; TIME FACTORS;

EID: 84858684824     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr560     Document Type: Article

References (19)

1. Jeon DS, Shin DO, Park SK et al. Treatment outcome and mortality among patients with multidrug-resistant tuberculosis in tuberculosis hospitals of the public sector. J Korean Med Sci 2011; 26: 33-41.
2. Ben-David D, Kordevani R, Keller N et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 2011.
3. Kwa AL, Low JG, Lee E et al. The impact of multidrug resistance on the outcomes of critically ill patients with Gram-negative bacterial pneumonia. Diagn Microbiol Infect Dis 2007; 58: 99-104.
4. O'Neill AJ, Huovinen T, Fishwick CW et al. Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. Antimicrob Agents Chemother 2006; 50: 298-309.
5. Levin BR, Lipsitch M, Perrot V et al. The population genetics of antibiotic resistance. Clin Infect Dis 1997; 24 Suppl 1: S9-16.
6. Komp Lindgren P, Marcusson LL, Sandvang D et al. Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections. Antimicrob Agents Chemother 2005; 49: 2343-51.
7. Foucault ML, Courvalin P, Grillot-Courvalin C. Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2009; 53: 2354-9.
8. Tam VH, Ledesma KR, Vo G et al. Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development. Antimicrob Agents Chemother 2008; 52: 3987-93.
9. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement M100-S17. CLSI, Wayne, PA, USA, 2007.
10. Abdelraouf K, Kabbara S, Ledesma KR et al. Effect of multidrug resistance-conferring mutations on the fitness and virulence of Pseudomonas aeruginosa. J Antimicrob Chemother 2011; 66: 1311-7.
11. Rozen DE, McGee L, Levin BR et al. Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 2007; 51: 412-6.
12. Sander P, Springer B, Prammananan T et al. Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob Agents Chemother 2002; 46: 1204-11.
13. Noto MJ, Fox PM, Archer GL. Spontaneous deletion of the methicillin resistance determinant, mecA, partially compensates for the fitness cost associated with high-level vancomycin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2008; 52: 1221-9.
14. Enne VI, Delsol AA, Roe JM et al. Rifampicin resistance and its fitness cost in Enterococcus faecium. J Antimicrob Chemother 2004; 53: 203-7.
15. Bjorkman J, Nagaev I, Berg OG et al. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 2000; 287: 1479-82.
16. McCallum N, Karauzum H, Getzmann R et al. In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance. Antimicrob Agents Chemother 2006; 50: 2352-60.
17. Gustafsson I, Cars O, Andersson DI. Fitness of antibiotic resistant Staphylococcus epidermidis assessed by competition on the skin of human volunteers. J Antimicrob Chemother 2003; 52: 258-63.
18. Andersson DI. The biological cost of mutational antibiotic resistance: any practical conclusions? Curr Opin Microbiol 2006; 9: 461-5.
19. Criswell D, Tobiason VL, Lodmell JS et al. Mutations conferring aminoglycoside and spectinomycin resistance in Borrelia burgdorferi. Antimicrob Agents Chemother 2006; 50: 445-52.